1. Home
  2. Vol 55, No 4 (2023)
  3. Nursyirwan

Assessment of Circulating Tumor Cells in Colorectal Cancer as an Adjunctive Non-invasive Diagnostic Method

Saskia Aziza Nursyirwan, Murdani Abdullah, Andri Sanityoso Sulaiman, Ikhwan Rinaldi, Dadang Makmun, Marcellus Simadibrata, Dimas Ramadhian Noor, Agustinus Wiraatmadja, Wifanto Saditya Jeo, Nur Rahadiani, Diah Rini Handjari, Hamzah Shatri

Abstract


Background: Colorectal cancer (CRC) is a significant contributor to cancer-related morbidity and mortality. Biopsy remains the gold standard for CRC diagnosis, but invasive testing may not be preferred as an initial diagnostic procedure. Therefore, alternative non-invasive approaches are needed. Circulating tumor cells (CTC) present in the bloodstream have great potential as a non-invasive diagnostic marker for CRC patients. This study aimed to assess the diagnostic potential of CTC in CRC as an adjunctive diagnostic method using a subjective manual identification method and laser capture microdissection at 40x magnification. Methods: A cross-sectional study was conducted on adult patients suspected to have CRC at Dr. Cipto Mangunkusumo National General Hospital, Jakarta, between November 2020 and March 2021. CTC analysis was performed using the negative selection immunomagnetic method with Easysep™ and the CD44 mesenchymal tumor marker. The identification and quantification of CTC were conducted manually and subjectively, with three repetitions of cell counting per field of view at 40x magnification. Results: Of 80 subjects, 77.5% were diagnosed with CRC, while 7.5% and 15% exhibited adenomatous polyps and inflammatory/hyperplastic polyps, respectively. The diagnostic analysis of CTC for detecting CRC (compared to polyps) using a CTC cutoff point of >1.5 cells/mL suggested sensitivity, specificity, and positive predictive value (PPV) of 50%, 88.89%, and 93.94%. Additionally, the negative predictive value (NPV), as well as the positive and negative likelihood ratio (PLR and NLR) were 34.04%, 4.5, and 0.56, respectively. The subjective manual identification and quantification of CTC were performed at 40x magnification using laser capture microdissection. Conclusion: This study assessed the diagnostic potential of CTC examination in CRC as an adjunctive diagnostic method using the subjective manual identification method and laser capture microdissection at 40x magnification. Despite the limitations associated with subjective cell counting, the results showed 50% sensitivity and 88.89% specificity in diagnosing CRC. Further studies are needed to optimize the manual identification process and validate the clinical utility of CTC analysis in CRC patients.


Keywords


Circulating tumor cells; Colorectal cancer; Cancer; Adenoma; Diagnosis

References


Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Kimman M, Norman R, Jan S, Kingston D, Woodward M. The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev [Internet]. 2012 [cited 2023 Aug 9];13(2):411–20. Available from: https://pubmed.ncbi.nlm.nih.gov/22524799/

Abdullah M, Sukartini N, Nursyirwan SA, et al. Gut microbiota profiles in early-and late-onset colorectal cancer: A potential diagnostic biomarker in the future. Digestion. 2021;102.

Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection-systematic review and meta-analysis. Radiology. 2011;259(2):393–405.

Świderska M, Choromańska B, Da̧browska E, et al. The diagnostics of colorectal cancer. Wspolczesna Onkol. 2014;18(1):1–6.

Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313–27.

Kolligs FT. Diagnostics and epidemiology of colorectal cancer. Visc Med [Internet]. 2016 [cited 2023 Aug 9];32(3):158–64. Available from: https://pubmed.ncbi.nlm.nih.gov/27493942/

Abdullah M, Fauzi A, Syam AF, et al. Hospital-based Survey on Knowledge and Attitude toward Colorectal Cancer Screening among Indonesian Population. Indones J Gastroenterol Hepatol Dig Endosc [Internet]. 2009;10(2):51–5. Available from: http://ina-jghe.com/journal/index.php/jghe/article/view/244%0Ahttp://ina-jghe.com/journal/index.php/jghe/article/download/244/275

Gado. Improving the yield of histological sampling in patients with suspected colorectal cancer during colonoscopy by Introducing a Colonoscopy Quality Assurance Program. Gastroenterol Res. 2011;4(4):157–61.

Harrison NM. Bowel cleansing before colonoscopy: Balancing efficacy, safety, cost, and patient tolerance. World J Gastrointest Endosc. 2016;8(1):4.

Vafaei S, Fattahi F, Ebrahimi M, Janani L, Shariftabrizi A, Madjd Z. Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: A systematic and analytical review. Cancer Manag Res. 2019;11:8669–98.

Burz C, Pop VV, Buiga R, et al. Circulating tumor cells in clinical research and monitoring patients with colorectal cancer. Oncotarget. 2018;9(36):24561–71.

Danese E, Montagnana M, Lippi G. Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer: which is ready for prime time? Ann Transl Med [Internet]. 2019 [cited 2023 Aug 9];7(21):610. Available from: http://dx.doi.org/10.21037/atm.2019.08.97http://dx.doi.org/10.21037/atm.2019.08.97

Yang C, Xia BR, Jin WL, Lou G. Circulating tumor cells in precision oncology: Clinical applications in liquid biopsy and 3D organoid model. Cancer Cell Int [Internet]. 2019;19(1):1–13. Available from: https://doi.org/10.1186/s12935-019-1067-8

Bankó P, Lee SY, Nagygyörgy V, Zrínyi M, Chae CH, Cho DH. Cell capture. Encycl Microfluid Nanofluidics. 2008;4:216.

Nordgård O, Tjensvoll K, Gilje B, Søreide K. Circulating tumor cells and DNA as liquid biopsies in gastrointestinal cancer. Br J Surg. 2018;105(2):e110–20.

Cohen SJ, Punt CJA, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(19):3213–21.

Yu H, Ma L, Zhu Y, Li W, Ding L, Gao H. Significant diagnostic value of circulating tumor cells in colorectal cancer. Oncol Lett. 2020;20(1):317–25.

Tsai WS, Chen JS, Shao HJ, et al. Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients. Sci Rep [Internet]. 2016;6(3):4–11. Available from: http://dx.doi.org/10.1038/srep24517

Yang C, Zhuang W, Hu Y, Zhu L. Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer. World J Surg Oncol. 2018;16(1):1–8.

Kamala T. An optimized immunomagnetic bead-based negative selection protocol for CD4 T-cell isolation from mouse lymph nodes and spleen. Scand J Immunol. 2008;67(3):285–94.

Sun C, Hsieh YP, Ma S, Geng S, Cao Z, Li L, et al. Immunomagnetic separation of tumor-initiating cells by screening two surface markers. Sci Rep [Internet]. 2017;7(October 2016). Available from: http://dx.doi.org/10.1038/srep40632

Tsunekuni K, Konno M, Haraguchi N, et al. CD44/CD133-positive colorectal cancer stem cells are sensitive to trifluridine exposure. Sci Rep. 2019;9(1):1–8.

Baek DH, Kim GH, Song GA, et al. Clinical potential of circulating tumor cells in colorectal cancer: A prospective study. Clin Transl Gastroenterol. 2019;10(7):1–9.

Dizdar L, Fluegen G, van Dalum G, et al. Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study. Mol Oncol. 2019;13(7):1548–58.


Full Text: PDF

Refbacks

  • There are currently no refbacks.